In summary, our findings highlight a previously unrecognized function of STING in regulating JAK1/STAT activation downstream of IFNAR signaling in endothelial cells and provide a new critical insight for future design and clinical application of STING agonists for cancer therapy. This evidence concerns the gene IFNAR1 and cancer.